HUTCHMED (China) (HCM) Assets Growth (1y) (2016 - 2026)
HUTCHMED (China) (HCM) Assets Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.22% |
| Dec 31, 2025 | -100.00% |
| Jun 30, 2025 | 40.85% |
| Dec 31, 2024 | 100,070,222,699.39% |
| Jun 30, 2024 | -2.82% |
| Dec 31, 2023 | -99.88% |
| Jun 30, 2023 | 8.64% |
| Dec 31, 2022 | -25.32% |
| Jun 30, 2022 | -6.17% |
| Dec 31, 2021 | -71.87% |
| Jun 30, 2021 | 142.20% |
| Dec 31, 2020 | 52.01% |
| Jun 30, 2020 | 6.13% |
| Dec 31, 2019 | -22.55% |
| Jun 30, 2019 | -14.31% |
| Dec 31, 2018 | -11.01% |
| Jun 30, 2018 | 67.67% |
| Dec 31, 2017 | 74.61% |
| Jun 30, 2017 | 6.77% |
| Dec 31, 2016 | 49.15% |